NSC |
Compound |
Enrichment |
Correlation |
NSC 759216 |
(3-(4-bromophenyl)-5-(1,3-diphenyl-1H-pyrazol-4-yl)-4,5-dihydropyrazol-1-yl)(4-methoxyphenyl)methanone |
0.0339770934764508 |
-0.076900776 |
NSC 763646 |
(E)-2-(2-(benzo[d][1,3]dioxol-5-yl)vinyl)-5-(3-methyl-1H-pyrazol-5-yl)-1,3,4-oxadiazole |
0.0339770934764508 |
0.38141215 |
NSC 88054 |
Null |
0.0339770934764508 |
0.36500293 |
NSC 285233 |
Null |
0.0339770934764511 |
0.3192581 |
NSC 128571 |
Ethanesulfonic acid, compd. with 2-chloro-5-[4-[2-chloro-4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) (8CI) |
0.0339770934764516 |
0.4007097 |
NSC 149286 |
1,4-Pentadien-3-one, 1,5-di-3-pyridyl- |
0.0339770934764516 |
0.58895302 |
NSC 169774 |
Bromocriptine methanesulfonate |
0.0339770934764516 |
0.58173596 |
NSC 20200 |
[Diisobutyl(phenoxyethoxy)ethyl]dimethylbenzylammonium chloride |
0.0339770934764516 |
0.32679914 |
NSC 205555 |
Butanoic acid, 2,3-dibromo-4-[(5-chloro-2-methoxyphenyl)amino]-4-oxo- |
0.0339770934764516 |
0.36423044 |
NSC 274539 |
Olivomycin D, 3B-O-(2,6-dideoxy-3-C-methyl-L-arabinohexopyranosyl)- |
0.0339770934764516 |
0.13768222 |